Radiopharm Doses First Patient in Phase I Prostate Cancer Radiotherapy Study
Alpha‑Emitting PSMA Therapies Gain Momentum Across Radiopharma Leaders
Ratio Therapeutics Highlights the Next Wave of Radiopharmaceutical Manufacturing Standards
Radiopharma Veterans From Novartis‑Built Platforms Strengthen Emerging Biotechs
Radiopharma Takes Center Stage as Global Biopharma Partnering Accelerates

Alex Mandel

Alex Mandel

Director Abdera Therapeutics

Seminars

Wednesday 22nd July 2026

Optimizing the Biodistribution & Pharmacokinetics of Abdera’s ROVEr Platform to Maximize Tumor Uptake

11:30 am

Designing a modular platform for optimizing pharmacokinetics to maximize tumor uptake while minimizing off-target exposure
Expanding the options available to engineer new functionality into antibody-based targeted radiotherapies
Enabling protein and linker engineering that tunes BioD and clearance for new targets

Alex Mandel - Director, Abdera Therapeutics - Expert Speaker at the 5th Targeted Radiopharmaceuticals Summit US 2026, San Diego, CA

View all Speakers

View Event Brochure